Allena stock: buy or sell?

ALNA stock price: $1.67 1.83% At close on November 15th, 2019

Updated on:
November 15th, 2019


Allena Pharmaceuticals closed yesterday at $1.67 and soared a fine 1.83%. On Wednesday ALNA collapsed a dreadful -9.47%.

Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States.

Should I buy Allena stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. That's why is so important to define your own trading strategy that matches with your character as inversor. At, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Allena Pharmaceuticals stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Allena Pharmaceuticals stock a buy?

Financial institutions and banks publish stock ratings everyday. At, we detected 7 ratings published for ALNA stock in the last month.

The general sentiment of these ratings is bullish for ALNA stock, with 7 positive ratings.
Is ALNA a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-6Credit Suisse GroupPositiveOutperform
2019-9-6Credit Suisse GroupPositiveOutperform
2019-8-5Credit Suisse Groupn/aOutperform
2019-7-10Credit Suisse Groupn/aOutperform

Allena stock analysis

Daily outlook

Allena Pharmaceuticals closed yesterday at $1.67 and soared a fine 1.83%.

Shares of Allena Pharmaceuticals closed yesterday at $1.67 and soared a fine 1.83%. In the last 9 days when ALNA stock price broke down the SMA200d line, it slid $-4.18 per share (-71.45%).

ALNA stock chart (daily)

Weekly outlook

Shares of Allena plunged a bloodcurdling -16.50% this week. Late October ALNA skyrocketed a super good 11.48% in just one week. With this, it's been 3 red weeks in a row, sliding $-3.99 or a -79.64%.

ALNA stock chart (weekly)

Allena stock price history

Allena IPO was on November 2nd, 2017 at $12.40 per share1. Since then, ALNA stock sliced a -86.50%, with a yearly average of -43.30%.

1: Adjusted price after possible price splits or reverse-splits.

Allena stock historical price chart

ALNA stock reached 52-week highs on November at $10.66, and all-time highs 2018-04-03 with a price of 17.56.

Allena stock price target is $22.40

Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we found 5 price predictions for Allena Pharmaceuticals stock:
ALNA stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-9-6Credit Suisse GroupReiterates$26.00$7.00-73.1%
2019-9-6Credit Suisse GroupLowers Target$26.00$7.00-73.1%
2019-8-5Credit Suisse GroupInitiatesn/a$26.00-
(in average)$26.00$22.40-14.0%
Moving in a range from $36.00 and $7.00, the price target for Allena Pharmaceuticals stock is $22.40. In average, analysts' outlook on ALNA price target is negative, downgrading the prediction by a -14.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

On March, Allena failed to meet the expectations of the analysts and posted a fatal EPS of $-0.46 per share when experts were expecting $-0.51.
ALNA earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In , Allena annual sales to million USD from marked in . , its profit margin (compared to revenues) to , that is million.

ALNA annual Sales and Income evolution

Quarterly financial results

Reported quarter income marked $-9.61 million with a profit margin of . Profit margin stayed stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, Allena sales marked a tight movement and remained constant a nan%. Looking back to recent quarterly results, Allena posted 5 negative quarters in a row.
ALNA quarterly Sales and Income evolution

Allena ownership

When you are planning to invest in shares of a stock, it's worth to review its ownership structure.

Allena shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 8.27% of all shares.

Bearish positions for ALNA stock account 0.00%, no big difference from last month.

For a better understanding, the following table shows ownership data compared to other related companies:

Market cap$39.2 M$650.6 M
Total shares23.5 M49.3 M
Float shares10.3 M43.3 M
  - Institutional holdings (%)88.4%50.8%
  - Insider holdings (%)8.3%6.0%
Shares in short selling0.0%0.0%

Allena summary

Friday, November 15th, 2019
Day range$1.56 - $1.75
Previous close$1.64
Session gain1.83%
Average true range$0.60
50d mov avg$4.24
100d mov avg$4.28
200d mov avg$5.16
Daily pattern
Weekly pattern

Allena performance

To measure stock performance is always good to benchmark with competitors or related stocks. In the following table, we compare Allena Pharmaceuticals performance to Array:
ALNAAllena Pharmaceut...-56.28%-68.19%-80.60%

Allena competitors

Creating a list of competitors for Allena it's a hard job. We selected just one public company that in our opinion is related to and can be considered Allena competitor: